Document:

QuickLinks
 -- Click here to rapidly navigate through this document
  

 
 

Exhibit 10.10    
  

 
  CONVERTIBLE PROMISSORY NOTE    
  

	$350,000.00	 	November 22, 2002
	

	
 	

 

        FOR
VALUE RECEIVED, PHARMAKINETICS LABORATORIES, INC., a Maryland corporation ("Maker"), hereby promises to pay to the order of Leslie B. Daniels ("Payee") the sum of Three
Hundred Fifty Thousand and No/100 Dollars ($350,000.00) or such lesser amount as shall then equal the outstanding principal amount hereof on May 1, 2003 (the "Maturity Date"), together with
interest accruing from the date hereof on the unpaid principal hereof at the rate of eight percent (8%) per annum. All sums hereunder are payable to Payee at the address specified in  Section 7
hereof or such other address as Payee may specify to Maker from time to time. 

        1.    Loans.    This Convertible Promissory Note (this "Note") evidences certain advances and extensions of credit
made prior to the date hereof and shall supersede and replace the promissory notes of Maker in favor of Payee dated April 3, 2002, May 14, 2002, May 30, 2002 and June 5,
2002. 

        2.    Payments.    The unpaid principal balance of this Note, plus all accrued and unpaid interest on the outstanding
principal hereof shall be due and payable on the Maturity Date, subject to any prior conversion(s) of this Note, as provided in this Note, and subject to the provisions hereof regarding the
acceleration of the maturity date of this Note. 

        3.    Prepayment.    Maker may at any time prepay in whole or in part the unpaid principal or accrued interest of this
Note which has not been converted as provided in this Note. Any payments on this Note shall be applied first to unpaid accrued interest hereon, and then to unpaid principal hereof. 

        4.    Conversion.    

        (a)  Payee
may, at Payee's option, at any time, and from time to time, prior to payment in full of this Note, convert the outstanding unpaid balance of this Note and any
accrued but unpaid interest (the "Conversion Amount"), in whole or in part (but only into full shares), into fully paid and non-assessable shares of the common stock, $0.005 par value, of
Maker (the "Common Shares"), at a price of $0.1585 per Common Share, subject to adjustment pursuant to Section 4(b) hereof (the "Conversion
Rate"). In order to exercise this conversion right, Payee must send written notice of the conversion to Maker at least two (2) days prior to the specified conversion date (a "Conversion
Notice"). On the specified conversion date (or as soon thereafter as is reasonably practicable), Maker shall issue to Payee a share certificate for the Common Shares acquired upon such conversion. 

        (b)  The
Conversion Rate shall be subject to adjustment: (i) if Maker at any time subdivides (by any stock split, stock dividend, recapitalization or otherwise) one or
more classes of its outstanding Common Shares into a greater number of shares, in which case the Conversion Rate in effect immediately prior to the subdivision will be proportionately reduced;
(ii) if Maker at any time combines (by reverse stock split or otherwise) one or more classes of its outstanding Common Shares into a smaller number of shares, in which case the Conversion Rate
in effect immediately prior to that combination will be proportionately increased; or (iii) upon the issuance by Maker of Common Shares, or of rights, options, warrants, or other securities
convertible into Common Shares, at a price per share that is less than the Conversion Rate, in which case, the Conversion Rate shall be adjusted so that it is equal to such per share price. 

        (c)  Notwithstanding
any other provisions of this Section 4 to the contrary, the conversion rights of Payee shall be
subject to compliance with all applicable federal and state securities laws, 

1

 

and Payee agrees to execute all required agreements and documents required by Maker to establish compliance with such laws. 

        (d)  Maker
shall at all times reserve and keep available and free of preemptive rights out of its authorized but unissued Common Shares, solely for the purpose of issuance
upon conversion of this
Note, that number of Common Shares as shall from time to time be sufficient to effect the conversion of this Note, and if at any time the number of authorized but unissued Common Shares shall not be
sufficient to effect the conversion of this Note, Maker shall take the corporate action necessary to increase the number of its authorized Common Shares to a number sufficient for this purpose. 

        (e)  Notwithstanding
anything in this Note to the contrary, the rights granted to Payee by this Section 4 (the
"Conversion Rights") shall not become effective unless and until the registered owners of 100% of the Class B Convertible Preferred Stock of the Maker (the "Preferred Holders") have delivered
written notice to Maker of the waiver of the Preferred Holders of the rights granted to the Preferred Holders pursuant to Section 4 of the PharmaKinetics Laboratories, Inc. Articles
Supplementary dated April 17, 2000 in connection with the Conversion Rights. 

        5.    Acceleration Upon Default.    Failure to pay this Note or any installment hereunder as it becomes due may, at
the election of the holder hereof, without notice, demand, presentment, notice of intent to accelerate, notice of acceleration, or any other notice of any kind which are hereby waived, mature the
principal of this Note and all accrued but unpaid interest thereon, if any, and, if the holder hereof makes such election, the same shall at once become due and payable and subject to those remedies
of the holder hereof. No failure or delay on the part of the holder hereof in exercising any right, power or privilege hereunder shall operate as a waiver thereof. 

        6.    Waiver.    Maker hereby waives grace, demand, presentment for payment, notice of nonpayment, protest, notice of
protest, notice of intent to accelerate, notice of acceleration and all other notices of any kind hereunder. 

        7.    Notices.    All notices, claims, demands and other communications hereunder shall be in writing and shall be
deemed given upon (a) confirmation of receipt of a facsimile transmission, (b) confirmed delivery by a standard overnight courier, (c) when delivered by hand or (d) the
expiration of five business days after the day when mailed by registered or certified mail (postage prepaid, return receipt requested), addressed to the respective parties at the following addresses
(or such other address for a party as shall be specified by like notice): 

        (a)    If to Payee:    

Leslie
B. Daniels

1040 Fifth Avenue

New York, New York 10028

Facsimile: (212) 319-0232 

        (b)    If to Maker:    

PharmaKinetics
Laboratories, Inc.

302 West Fayette Street

Baltimore, Maryland 21201

Attn: James M. Wilkinson, II, Ph.D.

Facsimile: (410) 385-1957 

        8.    Costs and Attorney's Fees.    Maker agrees to pay, in addition to all other amounts owing hereunder, all actual
expenses of collection of this Note, all court costs and reasonable attorney's fees incurred by the holder hereof on account of such collection. 

2

 

        9.    Headings; References.    All headings used herein are used for convenience only and shall not be used to
construe or interpret this Note. Except where otherwise indicated, all references herein to Sections refer to Sections hereof. 

        10.    Successors and Assigns.    All of the covenants, stipulations, promises, and agreements in this Note by or on
behalf of Maker shall bind its successors and assigns, whether so expressed or not. 

        11.    Governing Law.    This Note shall be governed by the laws of the State of Maryland, and the laws of such state
(other than conflicts of laws principles) shall govern the construction, validity, enforcement, and interpretation hereof, except to the extent federal laws otherwise govern the validity,
construction, enforcement, and interpretation hereof. 

        12.    Maximum Interest Rate.    Regardless of any provision contained herein, or in any other document executed in
connection herewith, the holder hereof shall never be entitled to receive, collect, or apply, as interest hereon, any amount in excess of the maximum rate of interest permitted to be charged from time
to time by applicable law, and in the event the holder hereof ever receives, collects, or applies, as interest, any such excess, such amount which would be excessive interest shall be deemed a partial
prepayment of the principal hereof and treated hereunder as such; and, if the principal hereof is paid in full, any remaining excess shall forthwith be paid to Maker. In determining whether or not the
interest paid or payable, under any specified contingency, exceeds the highest lawful rate, Maker and the holder hereof shall, to the maximum extent permitted under applicable law,
(a) characterize any nonprincipal payment as an expense, fee, or premium rather than as interest, (b) exclude voluntary prepayments and the effects thereof, and (c) spread the
total amount of interest throughout the entire contemplated term hereof; provided that if the indebtedness evidenced hereby is paid and performed in full prior to the end of the full contemplated term
thereof, and if the interest received for the actual period of existence thereof exceeds the maximum lawful rate, the holder hereof shall refund to Maker
the amount of such excess or credit the amount of such excess against the principal hereof, and in such event, the holder hereof shall not be subject to any penalties provided by any laws for
contracting for, charging, or receiving interest in excess of the maximum lawful rate. 

        IN
WITNESS WHEREOF, Maker has executed this Note as of the day and year first above written. 

	 	 	PHARMAKINETICS LABORATORIES,
	

	
 	

 	

 
	 	 	By:	/s/  JAMES M. WILKINSON II      
 James M. Wilkinson, II, Ph.D.
 President and CEO

3

QuickLinks

Exhibit 10.10

CONVERTIBLE PROMISSORY NOTETECHNOLOGY CONNECTIONS 2003 STOCK AWARD CONSULTING AND EMPLOYEE SERVICES PLAN

THIS CONSULTING AND EMPLOYEE SERVICES PLAN (the "Plan") is made as of the 17th
day of January 2003, by Technology Connections, Inc. (the "Company"), for the
Company's consultants and employees (the "recipients").

RECITALS:

The Company desires under agreement to grant compensation to recipients in
exchange for services  provided to the Company,  shares of the common stock of
the Company (the "Common Stock"), pursuant to the provisions set forth herein;

1.Grant of Shares. The Company shall grant to the Recipients from time to time
the following  shares of Common Stock (the  "Shares") in the Company.

         Class of Stock                                  Number of Shares
         ----------------------------------------------------------------
          Common                                            1,750,000

2. Services. Recipients shall provide bona fide services to the Company in
connection with filing of SEC 1934 Act reports and not in connection with
capital raising or market support activities.

3. Compensation. Recipient's compensation is the Shares identified herein.
The parties agree the Shares are valued at $.10 each. Recipients are
responsible for all income taxes.

4. Registration or Exemption. Notwithstanding anything to the contrary
contained herein, the Shares will be registered on Form S-8 Registration
Statement dated January 17th, 2003.

5. Delivery of Shares. The Company shall deliver to the Recipient such shares
for services pursuant to the agreement for services between the Company and
the recipient.

6. Waiver. No waiver is enforceable unless in writing and signed by such
waiving party, and any waiver shall not be construed as a waiver by any other
party or of any other or subsequent breach.

7.Amendments. This Plan may not be amended unless by the mutual Consent of all
of the parties hereto in writing.

8. Governing Law. This Plan shall be governed by the laws of the State of
North Carolina, and shall be the sole venue for any action arising hereunder.

9. Assignment and Binding Effect. Neither this Plan nor any of the rights,
interests or obligations hereunder shall be assigned by any party hereto
without the prior written Consent of the other parties hereto, except as
otherwise provided herein. This Plan shall be binding upon and for the benefit
of the parties hereto and their respective heirs, permitted successors,
assigns and/or delegates.

10. Integration and Captions. This Plan includes the entire understanding of
the parties hereto with respect to the subject matter hereof. The captions
herein are for convenience and shall not control the interpretation of this
Plan.

11. Legal Representation. Each party has been represented by independent legal
counsel in connection with this Plan, or each has had the opportunity to obtain
independent legal counsel and has waived such right, and no tax advice has been
provided to any party.

12. Construction. Each party acknowledges and agrees having had the opportunity
to review, negotiate and approve all of the provisions of this Plan.

13. Cooperation. The parties agree to execute such reasonable necessary
documents upon advice of legal counsel in order to carry out the intent and
purpose of this Plan as set forth herein above.

14. Hand-Written Provisions. Any hand-written provisions hereon, if any, or
attached hereto, which have been initialed by all of the parties hereto, shall
control all typewritten provisions in conflict therewith.

15. Fees, Costs and Expenses. Each of the parties hereto acknowledges and
agrees to pay, without reimbursement from the other party(ies), the fees,
costs, and expenses incurred by each such party incident to this Plan.

16.Consents and Authorizations. By the execution herein below, each party
acknowledges and agrees that each such party has the full right, power, legal
capacity and authority to enter into this Plan, and the same constitutes a
valid and legally binding Plan of each such party in accordance with the terms,
conditions and other provisions contained herein.

17. Gender and Number. Unless the context otherwise requires, references
in this Plan in any gender shall be construed to include all other genders,
references in the singular shall be construed to include the singular.

18. Severability. In the event anyone or more of the provisions of this Plan
shall be deemed unenforceable by any court of competent jurisdiction for any
reason whatsoever, this Plan shall be construed as if such unenforceable
provision had never been contained herein.

                                  EXHIBIT "A"

Item 1 - Plan Information

        (a) General Plan Information

1. The title of the Plan is: Technology Connections, Inc.-Year 2003 Stock
Award Plan ("Plan") and the name of the registrant whose securities are to be
offered pursuant to the Plan is Technology Connections, INC. ("Company").

2. The general nature and purpose of the Plan is to grant Employees and
Consultants 1,750,000 shares of the Company as compensation for services
rendered and service to be rendered to the Company.

3. To the best of Company's knowledge, the Plan is not subject to any of the
provisions of the Employee Retirement Income Security Act of 1974.

4. The Company shall act as Plan Administrator. The Company's address is:

TECHNOLOGY CONNECTIONS INC
13777 BALLANTYNE CORPORATE PLACE
SUITE 250
CHARLOTTE NC 28277

The telephone number of the Company is (704) 341-0698.

        (a) The Company, as administrator of the Plan, will merely issue to the
            employees and Consultant shares of Common Stock pursuant to the
            terms of the Plan.

        (b) Securities to be offered. Pursuant to the terms of the Plan, shares
            of the Company's common stock will be offered.

        (c) Employees Who May Participate in the Plan. Employees and Consultants
            who provide bona fide services to the Company may participate in the
            plan. Employees and Consultants are eligible to receive the
            securities provided the securities have been registered or are
            exempt from registration under the Securities Act of 1933, as
            amended (the "Act").

        (d) Purchase of Securities Pursuant to the Plan. The Company shall issue
            and deliver the securities to Employees and Consultants as soon as
            practicable.

        (e) Resale Restrictions. Employees and Consultants, after receipt of the
            Shares, may assign, sell, convey or otherwise transfer the
            securities received, subject to the requirements of the Act.

        (f) Tax Effects of Plan Participation. The Technology Connections, Inc.
            Year 2003 Stock Award Plan is not qualified under Sec. 401 of the
            Internal Revenue Code of 1986, as amended.

        (g) Investment of Funds. n/a

        (h) Withdrawal from the Plan; Assignment of Interest. Withdrawal or
            termination as to the Plan may occur upon mutual written Consent of
            the parties. Employees and Consultants have the right to assign or
            hypothecate Employees or Consultant's interest in the Plan, subject
            to Plan provisions.

        (i) Forfeitures and Penalties. n/a

        (j) Charges and Deductions and Liens Therefore. n/a

Item 2 -Registrant Information and Employee Plan Annual Information.

Registrant, upon oral or written request by Employees and Consultants, shall
provide, without charge, the documents incorporated by reference in Part II,
Item 3 of Company's Form S-8 Registration Statement for the securities as well
as any other documents required to be delivered pursuant to SEC Rule 428(b)
(17 CFR Section 230.428(b)). All requests are to be directed to the Company at
the address provided in paragraph (a)(4) above.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00046-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00046-of-00352.parquet"}]]